• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ebola Virus and Avian Retroviruses Have Common Evolutionary Origin

sharon sanders

Editor-in-Chief & President
Journal of Virology, December 2002, p. 12463-12472, Vol. 76, No. 24
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.24.12463-12472.2002
Copyright ? 2002, American Society for Microbiology. All Rights Reserved.

Covalent Modifications of the Ebola Virus Glycoprotein

Scott A. Jeffers,<SUP>1</SUP> David Avram Sanders,<SUP>1</SUP><SUP>*</SUP> and Anthony Sanchez<SUP>2</SUP>
Department of Biological Sciences, Purdue University, West Lafayette, Indiana 47907,<SUP>1</SUP> Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333<SUP>2</SUP>
Received 8 July 2002/ Accepted 6 September 2002
<!-- ABS -->The role of covalent modifications of the Ebola virus glycoprotein<SUP> </SUP>(GP) and the significance of the sequence identity between filovirus<SUP> </SUP>and avian retrovirus GPs were investigated through biochemical<SUP> </SUP>and functional analyses of mutant GPs. The expression and processing<SUP> </SUP>of mutant GPs with altered N-linked glycosylation, substitutions<SUP> </SUP>for conserved cysteine residues, or a deletion in the region<SUP> </SUP>of O-linked glycosylation were analyzed, and virus entry capacities<SUP> </SUP>were assayed through the use of pseudotyped retroviruses. Cys-53<SUP> </SUP>was the only GP<SUB>1</SUB> (
sim.gif
130 kDa) cysteine residue whose replacement<SUP> </SUP>resulted in the efficient secretion of GP<SUB>1</SUB>, and it is therefore<SUP> </SUP>proposed that it participates in the formation of the only disulfide<SUP> </SUP>bond linking GP<SUB>1</SUB> to GP<SUB>2</SUB> (
sim.gif
24 kDa). We propose a complete cystine<SUP> </SUP>bridge map for the filovirus GPs based upon our analysis of<SUP> </SUP>mutant Ebola virus GPs. The effect of replacement of the conserved<SUP> </SUP>cysteines in the membrane-spanning region of GP<SUB>2</SUB> was found to<SUP> </SUP>depend on the nature of the substitution. Mutations in conserved<SUP> </SUP>N-linked glycosylation sites proved generally, with a few exceptions,<SUP> </SUP>innocuous. Deletion of the O-linked glycosylation region increased<SUP> </SUP>GP processing, incorporation into retrovirus particles, and<SUP> </SUP>viral transduction. Our data support a common evolutionary origin<SUP> </SUP>for the GPs of Ebola virus and avian retroviruses and have implications<SUP> </SUP>for gene transfer mediated by Ebola virus GP-pseudotyped retroviruses.

http://jvi.asm.org/cgi/content/abst...e=2/1/2002&tdate=3/31/2003&resourcetype=HWCIT
 
Back
Top